Connection

Sacha Gnjatic to Carcinoma, Transitional Cell

Back to Details
This is a "connection" page, showing publications Sacha Gnjatic has written about Carcinoma, Transitional Cell.
Sacha Gnjatic
Connection Strength
0.150
Carcinoma, Transitional Cell
  1. Phase 2 Trial of Gemcitabine, Cisplatin, plus Ipilimumab in Patients with Metastatic Urothelial Cancer and Impact of DNA Damage Response Gene Mutations on Outcomes. Eur Urol. 2018 05; 73(5):751-759.
    View in: PubMed
    Score: 0.150
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.